Antimicrobial susceptibility of Pseudomonas aeruginosa: Results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 6, 2001, Pages 789-799

  Henwood, Caroline J ^a   Livermore, David M ^a   James, Dorothy ^a   Warner, Marina ^a   Gould, I ^b   Milne, K ^b   Walker, A M ^c   Dunkin, K T ^c   Rooney, P ^d   Craig, I ^d   Andrews, J ^e   Spencer, R C ^f   Wilson, G ^f   Brown, D F J ^g   Walpole, E ^g   Hosein, I ^h   Paull, A ^h   Grierson, J ⁱ   Grundy, S ⁱ   Teare, L ^j   Purton, C ^j   Mannion, P T ^k   Fraser, S B ^k   Thangkhiew, I ^l   Ackland, G ^l   Logan, M ^m   Burris, A ^m   Kent, R ⁿ   Westacott, R ⁿ   Youngs, E ^o   McCluskie, J ^o   Oppenheim, B ^p   Thornhill, C ^p   Mckay Ferguson, E ^q   Dance, D A B ^r   Cooper, N ^r   Pritchard, A ^s   Al Shafi, K ^t   James, P ^t   Yuan, M ^u   Sefton, A ^u   King, A ^v   Blake, A ^v   Howe, S A ^w   Gilbert, D S ^w   Bowker, K ^x   Tuck, A ^y   Bartlett, E ^y   Bates, J ^z   Kennedy, P ^z   more..

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c Bangor Hospital   (United Kingdom)

^d BELFAST CITY HOSPITAL   (United Kingdom)

^e CITY HOSPITAL   (United Kingdom)

^f BRISTOL ROYAL INFIRMARY   (United Kingdom)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

ⁱ CUMBERLAND INFIRMARY   (United Kingdom)

^j Chelmsford PHL   (United Kingdom)

^k Countess of Chester Hospital ^*  (United Kingdom)

^l Hospital of Coventry and Warwickshire   (United Kingdom)

^m GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

ⁿ IPSWICH HOSPITAL   (United Kingdom)

^o LINCOLN COUNTY HOSPITAL   (United Kingdom)

^p WITHINGTON HOSPITAL   (United Kingdom)

^q JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^r DERRIFORD HOSPITAL   (United Kingdom)

^s GLAN CLWYD HOSPITAL   (United Kingdom)

^t ROYAL GWENT HOSPITAL   (United Kingdom)

^u ROYAL LONDON HOSPITAL   (United Kingdom)

^v ST THOMAS HOSPITAL   (United Kingdom)

^w ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^x SOUTHMEAD HOSPITAL   (United Kingdom)

^y SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^z WORTHING HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACCURACY; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; CYSTIC FIBROSIS; HEALTH SURVEY; HOSPITAL; HUMAN; INTERMETHOD COMPARISON; MEDICAL SOCIETY; PREVALENCE; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; UNITED KINGDOM;

EID: 0034983569     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.6.789     Document Type: Article

References (19)

1. β-Lactamases of Pseudomonas aeruginosa
2. β-Lactamase lability and inducer power of newer β-lactam antibiotics in relation to their activity against β-lactamase-inducibility mutants of Pseudomonas aeruginosa
3. Patterns and modes of β-lactam resistance in Pseudomonas aeruginosa
4. Mechanisms of resistance to aminoglycosides in clinical isolates
5. Carbapenem-hydrolyzing β-lactamases
6. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broadspectrum β-lactams, including carbapenems
7. National survey of antibiotic resistance in Pseudomonas aeruginosa
8. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa
9. Quality of antimicrobial susceptibility testing in the UK: A Pseudomonas aeruginosa survey revisited
10. BSAC standardized disc susceptibility testing method
11. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: Distribution of blaB and characterization of a novel metallo-β-lactamase gene, blaB3, in the type strain NCTC 10016
12. Antimicrobial resistance in European isolates of Pseudomonas aeruginosa. European Sentry Participants
13. Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents
14. A study of the mechanisms involved in imipenem resistance in Pseudomonas aeruginosa isolates from Japan
15. Carbapenem-hydrolyzing metallo-β-lactamases in Pseudomonas aeruginosa
16. Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles
17. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
18. MIC audit for routine ciprofloxacin sensitivity testing
19. Sensitivity testing of ciprofloxacin for Pseudomonas aeruginosa